Thus, SMN protein deficiency leads to disruption of normal cytoskeleton development resulting in shorter axons in SMA patients, which may partly explain the lower NFs levels in SMA patients than in ALS patients. The gene discussed is SMN1; the disease is amyotrophic lateral sclerosis.